Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Cited by (1,001)

Items 901–1,000 of 1,001

1. Hesperetin derivative decreases CCl4‐induced hepatic fibrosis by Ptch1‐dependent mechanisms
   Sai Zhu, Xin Chen, Siyu Chen, Ao Wang, Sha Wu, Yuanyuan Wu, Miao Cheng, Jinjin Xu, Xiaofeng Li, Cheng Huang et al. · 2022 · Journal of Biochemical and Molecular Toxicology
2. T-cadherin is a novel regulator of pericyte function during angiogenesis
   Boris Dasen, Sébastien Pigeot, Gordian Born, Sophie Verrier, Olga Rivero, Petra Stephanie Dittrich, Iván Martín, Maria Filippova · 2023 · American Journal of Physiology-Cell Physiology
3. Stattic alleviates pulmonary fibrosis in a mouse model of rheumatoid arthritis–relevant interstitial lung disease
   Lihu Xie, Youyou Li, Wenting Tang, Qingxiu C. Zhang, Cong Luo, Xiaoping Long · 2023 · Experimental Biology and Medicine
4. Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted
   Yang-Huan He, Jiaxing Pan, Leiming Xu, Ting Gu, Yuanwen Chen · 2023 · World Journal of Hepatology
5. Cross‐talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis
   Chuanfu Ren, Zhi Yang, En Xu, Xing Kang, Xingzhou Wang, Qi Sun, Chao Wang, Liang Zhang, Ji Miao, Banxin Luo et al. · 2023 · Cancer Science
6. Integrins, myofibroblasts, and organ fibrosis
   Michel Fausther, Jonathan A. Dranoff · 2014 · Hepatology
7. CD4+Foxp3+ T cells promote aberrant immunoglobulin G production and maintain CD8+ T‐cell suppression during chronic liver disease
   Dana Tedesco, Manoj Thapa, Sanjeev Gumber, Elizabeth J. Elrod, Khalidur Rahman, Chris Ibegbu, Joseph F. Magliocca, Andrew B. Adams, Frank A. Anania, Arash Grakoui · 2016 · Hepatology
8. The detached pericyte hypothesis: A novel explanation for many puzzling aspects of tumorigenesis
   Stuart G. Baker · 2018 · Organisms. Journal of Biological Sciences
9. Cortistatin regulates fibrosis and myofibroblast activation in experimental hepatotoxic‐ and cholestatic‐induced liver injury
   Raquel Benítez, Marta Caro, Eduardo Andrés‐León, Francisco O’Valle, Mario Delgado · 2021 · British Journal of Pharmacology
10. Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1
    Wenwen Wang, Min Yan, Qiuhong Ji, Jinbiao Lu, Yuhua Ji, Juling Ji · 2015 · PeerJ
11. Adenovirus‑mediated knockdown of activin A receptor type�2A attenuates immune‑induced hepatic fibrosis in mice and inhibits interleukin‑17‑induced activation of primary hepatic stellate cells
    Hongjun Zhang, Baoling Ju, Ying Nie, Baohui Song, Yuanhong Xu, Ping Gao · 2018 · International Journal of Molecular Medicine
12. 27-Hydroxycholesterol induces liver fibrosis via down-regulation of trimethylation of histone H3 at lysine 27 by activating oxidative stress; effect of nutrient interventions
    Kai Jiao, Keke Yang, Jie Wang, Yifan Ni, Chunyan Hu, Jiao Liu, Ming Zhou, Jin Zheng, Zhong Li · 2023 · Free Radical Biology and Medicine
13. Effectiveness and mechanisms of mesenchymal stem cell therapy in preclinical animal models of hepatic fibrosis: a systematic review and meta-analysis
    Xuesong Wang, Yue Wang, Wenming Lu, Jiayang Qu, Yang Zhang, Junsong Ye · 2024 · Frontiers in Bioengineering and Biotechnology
14. Tension-induced directional migration of hepatic stellate cells potentially coordinates liver fibrosis progression
    Lyu Zhou, Ziao Shi, Xuesi Yang, Jia’nan Zeng, Zhifeng You, Yuying Zhang, Zhiyue Zhu, Zhiqiang Liu, Yudi Niu, Hongsheng Yu et al. · 2025 · Nature Biomedical Engineering
15. Oral delivery of chitosan-bilirubin nanoparticles alleviates hepatic inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
    Afia Tasnim Rahman, Jinyoung Choi, Woojin Kyung, Suyoung Kang, Seojung Lee, Sangyong Jon · 2025 · Biomaterials
16. AMPK maintains the activation of hepatic stellate cells through mitophagy-induced metabolic reprogramming
    Hanmin Wang, Guanzhen Wang, Tao Yin, Hao Li, Hanlin Wang, Yikai Shao, Yuanyuan Li, Rong Hua, Jia Li, Yi Zang · 2025 · Journal of Molecular Cell Biology
17. Stratifying cholangiocarcinoma: tumor microenvironment, molecular drivers, and novel immunotherapeutic approaches
    Cindy Xinqi Liu, Carmen Chak-Lui Wong · 2025 · Clinical and Molecular Hepatology
18. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl4-induced fibrotic mice model
    Xiang Li, Yue Xing, Dechang Mao, Ying Lü, Yunqi Luan, Mei Feng Xu, Hongmin Wang, Chunyan Li, Yanmei Li, Shuangqing Zheng et al. · 2020 · Biomedicine & Pharmacotherapy
19. SARA suppresses myofibroblast precursor transdifferentiation in fibrogenesis in a mouse model of scleroderma
    Katia Corano Scheri, Xiaoyan Liang, Vidhi Dalal, I. Caroline Le Poole, John Varga, Tomoko Hayashida · 2022 · JCI Insight
20. BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells
    Zhongyang Jiang, Ximei Ma, Xiaohui Luan, Zhen‐Yu Liuyang, Yiyang Hong, Yuan Dai, Qinghua Dong, Guanyu Wang · 2023 · World Journal of Gastroenterology
21. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
    Pietro Guerra, Andréa Martini, Patrizia Pontisso, Paolo Angeli · 2023 · Cancers
22. Characterization of human stem cell-derived hepatic stellate cells and liver sinusoidal endothelial cells during extended in vitro culture
    Ingrid Wilhelmsen, Mikel Amirola Martinez, Justyna Stokowiec, Chencheng Wang, Aleksandra Aizenshtadt, Stefan Johannes Karl Krauss · 2023 · Frontiers in Bioengineering and Biotechnology
23. Bromodomain protein 4 is a key molecular driver of TGFβ1-induced hepatic stellate cell activation
    Feifan Xu, Sidan Lu, Nachuan Pan, Feifei Zhao, Xin Jia, Shouwei Wang, Yali Zhang, Yajun Zhou · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
24. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)
    Anusha Hemamali Tennakoon, Takeshi Izawa, Kavindra K. Wijesundera, Chisa Katou-Ichikawa, Miyuu Tanaka, Hossain M. Golbar, Mitsuru Kuwamura, Jyoji Yamate · 2015 · Experimental and Molecular Pathology
25. MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1
    Peiqin Wang, Shu-Juan Lei, Xiaohang Wang, Wenping Xu, Ping‐Fang Hu, Fei Chen, Xin Zhang, Chuan Yin, Wei‐Fen Xie · 2019 · Biochemistry and Cell Biology
26. Apoptotic effects of hsian‐tsao (Mesona procumbens Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase‐3 pathways
    Yung‐Hsiang Yeh, Chun‐Ya Liang, Mao‐Liang Chen, Fu‐Ming Tsai, Yi‐Ying Lin, Ming‐Cheng Lee, Jiunn‐Sheng Wu, Chan‐Yen Kuo · 2019 · Food Science & Nutrition
27. XRCC4 c.1394G>T Single Nucleotide Polymorphisms and Breast Cancer Risk among Filipinos
    Julius Adrie Garcia, Noel Angelo Kalacas, Teresa Sy Ortin, Maria Cristina Ramos, Pia Marie Albano · 2019 · Asian Pacific Journal of Cancer Prevention
28. Wnt ligand and receptor patterning in the liver
    Eider Valle-Encinas, Trevor C. Dale · 2019 · Current Opinion in Cell Biology
29. Expression and clinical significance of inhibitory receptor Leukocyte-associated immunoglobulin-like receptor-1 on peripheral blood T cells of chronic hepatitis B patients
    Yurong Gu, Yanhua Bi, Huan Jun Wei, Jing Li, Zexuan Huang, Chunhong Liao, Weixin Liao, Yuehua Huang · 2021 · Medicine
30. Ethanol extract of Pharbitis nil ameliorates liver fibrosis through regulation of the TGFβ1-SMAD2/3 pathway
    Hyun Jin Jung, Kyohee Cho, Sun Yeou Kim, Je Kyung Seong, Seung Hyun Oh · 2022 · Journal of Ethnopharmacology
31. New approaches for fibrosis regression in alcoholic cirrhosis
    Wajahat Zafar Mehal, Uyen Kim To · 2016 · Hepatology International
32. TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor
    Sabine Klein, Carola‐Ellen Kleine, Andrea Pieper, M Granzow, Sebastian Gautsch, M Himmit, K Kahrmann, Robert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno et al. · 2019 · Scientific Reports
33. Slit2 signaling contributes to cholestatic fibrosis in mice by activation of hepatic stellate cells
    Changzheng Li, Guizhi Yang, Liteng Lin, Yuanyuan Xuan, Sishan Yan, Xiaoqian Ji, Fenyun Song, Min-qiang Lu, Tian Lan · 2019 · Experimental Cell Research
34. Qianggan Ruanjian Pill ameliorates liver fibrosis through regulation of the TGF-β1/Smad and PI3K/AKT signalling pathways
    Qunying Feng, Qinghua Zhao, Shuaiyong Qu, Yiju Zhao, Kunlun Li, Bo Yuan, Qinzheng Chang, Jingjiang Xu, Hongxia Wang, Yongqin Zhu et al. · 2024 · Journal of Ethnopharmacology
35. Periductal fibroblasts participate in liver homeostasis, fibrosis, and tumorigenesis
    Shan-Shan Wang, Jia Yuan, Xinyu Thomas Tang, Xiujuan Yin, Ke Fang, Lin Veronica Chen, Zhenggang Ren, Bo O. Zhou · 2025 · The Journal of Experimental Medicine
36. Single-cell RNA sequencing advances in revealing the development and progression of MASH: the identifications and interactions of non-parenchymal cells
    Meng Ning, Donghui Lu, Dong Liang, Pei‐Gen Ren · 2025 · Frontiers in Molecular Biosciences
37. AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction–associated steatotic liver disease
    Naoto Fujiwara, Yuki Matsushita, Mina Tempaku, Yutaro Tachi, Genki Kimura, Kiyora Izuoka, Yuki Hayata, Satoshi Kawamura, Akiko Eguchi, Takuma Nakatsuka et al. · 2025 · Hepatology
38. AEBP1 or ACLP, which is the key factor in inflammation and fibrosis?
    Zhang Runtian, Han Wenqiang, Shen Zimeng, Wang Tianyu, Zhong Jingquan · 2025 · International Journal of Biological Macromolecules
39. Nuclear Pirin promotes HCC by acting as a key inflammation-facilitating factor
    Huanhuan Ma, Tingyan Cao, Fengqiong Zhang, Dachao Sun, Lili Chen, Yao Lin, Shuqing Lai, Bin Jiang, Yanming Zhou, Jun A You et al. · 2025 · Gut
40. Liver specific, systemic and genetic contributors to alcohol-related liver disease progression
    Bernd Schnabl, Gavin E. Arteel, Felix Stickel, Jan Georg Hengstler, Nachiket Vartak, Ahmed Ghallab, Steven Dooley, Yujia Li, Robert F. Schwabe · 2022 · Zeitschrift für Gastroenterologie
41. Paxillin regulates liver fibrosis via actin polymerization and ERK activation in hepatic stellate cells
    Nour Hijazi, Zengdun Shi, Don C. Rockey · 2023 · Journal of Cell Science
42. Regulation of High-fat Diet-induced Liver Fibrosis by SOCS1 Expression in Hepatic Stellate Cells
    Rajani Kandhi, Alfredo Menéndez, Sheela Ramanathan, Subburaj Ilangumaran · 2023 · Journal of Clinical and Experimental Hepatology
43. Protective hepatocyte signals restrain liver fibrosis in metabolic dysfunction–associated steatohepatitis
    Marcella Steffani, Yana Geng, Utpal B. Pajvani, Robert F. Schwabe · 2024 · Journal of Clinical Investigation
44. Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs
    Cheng Sun, Chan Zhou, Kaveh Daneshvar, Amel Ben Saad, Arcadia J. Kratkiewicz, Benjamin J. Toles, Nahid Arghiani, Anja Hess, Jennifer Y. Chen, Joshua V. Pondick et al. · 2024 · Hepatology
45. Adenoviral overexpression of Lhx2 attenuates cell viability but does not preserve the stem cell like phenotype of hepatic stellate cells
    Berit Genz, Maria Thomas, Brigitte M. Pützer, Marcin Siatkowski, Georg Fuellen, Brigitte Vollmar, Kerstin Abshagen · 2014 · Experimental Cell Research
46. Schistosoma japonicum soluble egg antigen inhibits TNF-α-induced IL-34 expression in hepatic stellate cells
    Liuting Chen, Yang Yu, Ertao Liu, Lian Duan, Dandan Zhu, Jinling Chen, Jia Mu Dai, Yinong Duan · 2018 · Parasitology Research
47. A New Murine Liver Fibrosis Model Induced by Polyhexamethylene Guanidine-Phosphate
    Min-Jeong Kim, Sumin Hur, Kwang H. Kim, Yejin Cho, Keunyoung Kim, Ha Ryong Kim, Ki Taek Nam, Kyung‐Min Lim · 2021 · Biomolecules & Therapeutics
48. The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis
    Nour Hijazi, Don C. Rockey, Zengdun Shi · 2022 · Biocell
49. Molecular Mechanism Network Pharmacology and Bioinformatics Research of Qingrejiedu Decoction in Treatment of Liver and Gallbladder Neoplasms
    2023 · Pakistan Veterinary Journal
50. Potential Use of Biological Proteins for Liver Failure Therapy
    Kazuaki Taguchi, Keishi Yamasaki, Hakaru Seo, Masaki Otagiri · 2015 · Pharmaceutics
51. Stellate Cells, Portal Myofibroblasts, and Epithelial-to-Mesenchymal Transition
    Yukinori Koyama, Ping Wang, David A. Brenner, Tatiana Kisseleva · 2015 · Elsevier eBooks
52. Design of a Gene Panel to Expose the Versatile Role of Hepatic Stellate Cells in Human Liver Fibrosis
    Fransien van Dijk, Christa M. Hazelhoff, Eduard Post, Grietje Harmanna Prins, Krista Rombouts, Klaas Poelstra, Peter Olinga, Leonie Beljaars · 2020 · Pharmaceutics
53. Unraveling the activation process and core driver genes of HSCs during cirrhosis by single-cell transcriptome
    Xia Li, Qiang Wang, Liang Ai, Ke Cheng · 2023 · Experimental Biology and Medicine
54. Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer
    Gianmarco Villano, Patrizia Pontisso · 2024 · Frontiers in Immunology
55. Hepatic Fibrosis and Liver Cancer
    Aina Anton, Scott L. Friedman, Bruno Cogliati · 2025 · Seminars in Liver Disease
56. Lack of PCK1 in hepatic stellate cells causes liver fibrosis by fueling tricarboxylic acid cycle and increasing glycolysis
    Eva Nóvoa, Tamara Parracho, Julica Inderhees, Amaia Rodriguez, Cristina Riobello, Jose Iglesias-Moure, Anabel Fernández‐Iglesias, Sara Martínez-Martínez, Ana Senra, Samuel Seoane et al. · 2026 · Cell Metabolism
57. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice
    Michaela A. A. Fuchs, Julia Schrankl, Christina Leupold, Charlotte Wagner, Armin Kurtz, Katharina A.E. Broeker · 2022 · American Journal of Physiology-Renal Physiology
58. FAT10 Silencing Prevents Liver Fibrosis through Regulating SIRT1 Expression in Hepatic Stellate Cells
    Weihong Zheng, Fei Guan, Guoxing Xu, Yikai Yu, Jun Xiao, Xiaowei Huang · 2023 · International Journal of Medical Sciences
59. Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis
    Xiaoyan Wu, Yuwen Zhu, Yan Guo, Zhigang Zhao, Zheng Li · 2023 · Life Sciences
60. The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts
    Massimiliano Cadamuro, Giorgia Nuozzi, Paolo Simioni, Luca Fabris · 2023 · Hepatoma Research
61. mTOR signalling controls the formation of smooth muscle cell-derived luminal myofibroblasts during vasculitis
    Angus T. Stock, Sarah A. Parsons, Jacinta A Hansen, Damian B. D’Silva, Graham Starkey, Aly Fayed, Xin Yi Lim, Rohit D’Costa, Claire L. Gordon, Ian P. Wicks · 2024 · EMBO Reports
62. Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
    Richard Philip Grose, Stacey J. Coleman, Hemant Mahendrakumar Kocher · 2014 · Journal of Hepatocellular Carcinoma
63. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride–Induced Hepatic Fibrosis in Mice
    Yan Jiang, Yuanyuan Zhao, Fuchu He, Haijian Wang · 2018 · Human Gene Therapy
64. Multiple functions of MLKL in liver fibrosis, from necroptosis to hepatic stellate cell activation
    Valéria Pistorio, Chantal Housset, Jérémie Gautheron · 2022 · Theranostics
65. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice
    Kyoung‐Jin Chung, Aigli‐Ioanna Legaki, Grigorios Papadopoulos, Bettina Gercken, Janine Gebler, Robert F. Schwabe, Triantafyllos Chavakis, Antonios Chatzigeorgiou · 2023 · International Journal of Molecular Sciences
66. Hepatic myofibroblasts derived from Schistosoma mansoni-infected mice are a source of IL-5 and eotaxin: controls of eosinophil populations in vitro
    Ligia Almeida Paiva, Camila Brand, Christianne Bandeira‐Melo, Patrícia Torres Bozza, Marcia Cury El-Cheikh, Patrı́cia Silva, Radovan Borojević, Sandra A.C. Perez · 2015 · Parasites & Vectors
67. Environmental peer pressure: CD4+ T cell help in tolerance and transplantation
    Dana Tedesco, Arash Grakoui · 2017 · Liver Transplantation
68. Pharmacologic management of primary sclerosing cholangitis: what’s in the pipeline?
    Jaspreet S. Suri, Vilas R. Patwardhan, Alan Bonder · 2019 · Expert Review of Gastroenterology & Hepatology
69. A novel role for hepatic stellate cells in pathogenesis of visceral leishmaniasis
    Naglaa H. Shoukry, Thomas Fabre, Chandrashekhar R. Gandhi · 2015 · Hepatology
70. Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction
    Carter, James K., Tsai, Ming-Chao, Venturini, Nicholas, Hu, Jiangting, Lemasters, John J., Torres Martin, Miguel, Sia, Daniela, Wang, Shuang, Lee, Youngmin A., Friedman, Scott L. · 2024 · Hepatology
71. Targeting histone methylation and demethylation for non-alcoholic fatty liver disease
    Yuanbing Du, Zhangxu He, Sasa Jin, Gang Y Jin, Kaiyue Wang, Feifei Yang, Jingyu Zhang · 2024 · Bioorganic Chemistry
72. Cellular Crosstalk Promotes Hepatic Progenitor Cell Proliferation and Stellate Cell Activation in 3D Co-culture
    Maya W. Haaker, Jung‐Chin Chang, Brian K. Chung, Tobias S. Pieper, Falko Noé, Tongtong Wang, Niels Geijsen, Martin Houweling, Christian Wolfrum, Arie B. Vaandrager et al. · 2025 · Cellular and Molecular Gastroenterology and Hepatology
73. Targeting LOXL1-expressing Hepatic Stellate Cell Inhibits Fibrogenesis and Sinusoid Angiogenesis via LOXL1/RUNX1/VEGFA Axis During Progression of Liver Fibrosis
    Xuzhen Yan, Qi Han, Yiwen Wang, Weiyu Li, Ning Zhang, Fan Xu, Wei Chen, Hong You, Aiting Yang · 2025 · Cellular and Molecular Gastroenterology and Hepatology
74. Advanced strategies based on nanomedicine for Liver fibrosis treatment
    Lu Zhang, Tingting Liu, Huan Shen, Bo-Heng Liu, Yun Mei, Yang Liu, Shuo Chen, Xingcong Ma, Chenyang He, Tinghua Hu et al. · 2025 · International Journal of Pharmaceutics
75. Reprogramming offspring liver health: maternal indole supplementation as a preventive strategy against MASLD
    Ashok Mandala, Ram Babu Undi, Rachel C. Janssen, Kameron Y. Sugino, Wanke Zhao, Benjamin N. Nelson, April M. Teague, Nikhil Y. Patil, Karin A. Zemski Berry, Rohan Varshney et al. · 2025 · EBioMedicine
76. Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH
    Kenneth Li, Vardhman Kumar, Tran To, Álvaro González‐Domínguez, Janvi Huria, Maylene Yu, Bruno Cogliati, Chittampalli N. Yashaswini, C M Miller, Andrea D. Branch et al. · 2026 · Cell Reports
77. Nanotherapy targeting liver sinusoidal endothelial cells in liver fibrosis
    Lingfeng Zhang, Jia-Wen Ru, Su-Qing Liang, Meng-Meng Zhang, Chun-Yu Zhang, Jia-Qi Liu, Yi Wang, Tian‐Jiao Zhou, Xian Wu Cheng, Lei Xing et al. · 2026 · Journal of Controlled Release
78. Perspective: The Mechanobiology of Hepatocellular Carcinoma
    Abigail E. Loneker, Rebecca G. Wells · 2021 · Cancers
79. CD8+ T cell memory is sustained in mice by hepatic stellate cells
    Yi‐Ting Chen, Yu‐Chia Su, Yee‐Ern Or, Chin‐Fu Cheng, John T. Kung · 2022 · Hepatology
80. Fate tracking reveals differences between Reelin+ hepatic stellate cells ( HSCs) and Desmin+ HSCs in activation, migration and proliferation
    Ning Chen, Shenghui Liu, Dan Qin, Dian Guan, Yaqing Chen, Chenjiao Hou, Songyun Zheng, Liqiang Wang, Xiangmei Chen, Wei Chen et al. · 2023 · Cell Proliferation
81. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies
    Serena Babboni, Pier Giuseppe Vacca, Ludovica Simonini, Daniele Pezzati, Caterina Martinelli, Francesco Frongillo, Giuseppe Bianco, Emanuele Marciano, Giuseppina Basta, Davide Ghinolfi et al. · 2024 · Journal of Clinical Medicine
82. Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease
    Valentin Blank, Thomas Karlas, Ulf Anderegg, Johannes Wiegand, Josi Arnold, Linnaeus Bundalian, Gabriela‐Diana Le Duc, Christiane Körner, Thomas Ebert, Anja Saalbach · 2024 · Liver International
83. Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells
    Zi-Xuan Qiu, Lin-Xiang Huang, Xiaoxiao Wang, Zilong Wang, Xiaohe Li, Bo Feng · 2024 · Journal of Clinical and Translational Hepatology
84. Angiotensin II depends on hippo/YAP signaling to reprogram angiogenesis and promote liver fibrosis
    Yanan Zhou, Pan Liang, Tao Bi, Bo Tang, Xiaoning Zhu, Xinyue Liu, Hong Wang, Hongping Shen, Qin Sun, Sijin Yang et al. · 2024 · Cellular Signalling
85. Purinergic Signaling in Non-Parenchymal Liver Cells
    Esperanza Mata Martínez, María Guadalupe Ramírez‐Ledesma, Genaro Vázquez‐Victorio, Rolando Efraín Hernández-Muñoz, Mauricio Díaz‐Muñoz, Francisco Gabriel Vázquez‐Cuevas · 2024 · International Journal of Molecular Sciences
86. Impact of heterogeneity in liver matrix and intrahepatic cells on the progression of hepatic fibrosis
    Zhongtao Sun, Guobao Chen · 2024 · Tissue and Cell
87. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
    Vinay Sundaram, Timothy R.M. Morgan · 2018 · Clinics in Liver Disease
88. Physiology of cellular demise: Apoptosis, necrosis, and autophagy
    Darshpreet Kaur, Rahul R Deshmukh · 2020 · Elsevier eBooks
89. Identification of the Different Gene Expression Characteristics from Liver Cirrhosis to Hepatocellular Carcinoma Using Single-Cell Sequencing Analyses
    Xin Xing, Jian Song · 2021 · Journal of Immunology Research
90. Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
    Tatsuya Tsukui, Shigeyuki Shichino, Takeshi Shimaoka, Satoshi Ueha, Kouji Matsushima · 2016 · Springer eBooks
91. Live-cell imaging of human liver fibrosis using hepatic micro-organoids
    Guan, Yuan, Fang, Zhuoqing, Hu, Angelina, Roberts, Sarah, Wang, Meiyue, Ren, Wenlong, Johansson, Patrik K., Heilshorn, Sarah C., Enejder, Annika, Peltz, Gary · 2025 · JCI Insight
92. Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease
    Huihui Zou, Sai Wang, Chenjun Huang, Steven Dooley, Nadja M. Meindl‐Beinker · 2025 · American Journal Of Pathology
93. Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy
    Rong Fu, Fuyuan Zhang, Junliang Fu, Yuqian Li, Xiangming Zhu, Qian Ding, Yi Zhun Zhu · 2025 · Metabolism and Target Organ Damage
94. Imperfect repair in aging: senescent cells and the hepatic fibrotic niche
    Juyeon Kim, Minseong Kim, Chuna Kim · 2026 · BMB Reports
95. Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells
    Christian Freise, Hyunho Lee, Christopher Chronowski, Doug W. Chan, Jessica Cziomer, Martin Rühl, Tarkan Dagdelen, M LOESEKANN, Ulrike Erben, André Catic et al. · 2021 · PLoS ONE
96. miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1
    Wenchao Pan, Yadong Wang, Caiyan Zhao · 2023 · Scandinavian Journal of Gastroenterology
97. Molecular mechanisms underlying SARS-CoV-2 hepatotropism and liver damage
    Jorge Fabián Quarleri, M. Victoria Delpino · 2024 · World Journal of Hepatology
98. Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy
    Kenneth K. Tanabe, David M. Zahrieh, Carrie A. Strand, Yujin Hoshida, Thomas James Flotte, Gary Della’Zanna, Asad Umar, Kenneth D. Chavin, Sean Patrick Cleary, Naoto Kubota et al. · 2024 · Gastro Hep Advances
99. A Novel Protein‐Polysaccharide Oral Nanoemulsion Targeting Activated Hepatic Stellate Cells to Enhance the Therapeutic Effect of Pirfenidone on Fibrosis After Transarterial Chemoembolization for Liver Cancer
    Zhimei Cheng, Shan Xu, Yi Lei, Huizhou He, Runbin Sun, Xingle Jin, C Huang, Yuhao Zheng, Jianqing Peng, Lei Tang et al. · 2025 · Advanced Functional Materials
100. Engineered Perfusable Hepatic Fibrosis Model via Embedded Sacrificial Bioprinting Recapitulates Stiffness‐Driven Fibrogenesis
     Lv, Weikang, Naren, Tuya, Aazmi, Abdellah, Yu, Haoran, Wang, Yujun, Lee, Jie Ying, Yu, Mengfei, Jia, Junjun, Jiang, Xiuxiu, Yang, Huayong et al. · 2026 · Advanced Materials